Article

Targeting the p53 pathway to treat Malignant Rhabdoid and Atypical Teratoid Rhabdoid Tumors

2022-10-06

Abstract excerpt

<title>Abstract</title> <p>Rhabdoid tumors (RTs) predominantly affect young children and are among the deadliest pediatric solid tumors. Despite multimodal therapy consisting of surgery, radiation, and chemotherapy, children with these tumors have median survival of less than one year. RTs can arise throughout the body, including the central nervous system (CNS) where they are called atypical teratoid rhabdoid tu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5f36156a-d172-5a7d-8bf4-079b0c088512
DOI: 10.21203/rs.3.rs-2094243/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeting the p53 pathway to treat Malignant Rhabdoid and Atypical Teratoid Rhabdoid TumorsDOI 10.21203/rs.3.rs-2094243/v1Read

Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumorsSemantic proximity Read

MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsSemantic proximity Read

Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.Semantic proximity Read

Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventionsSemantic proximity Read

Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatinSemantic proximity Read

Atypical Teratoid Rhabdoid Tumour : From Tumours to TherapiesSemantic proximity Read

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilitiesSemantic proximity Read

Identification and validation of a non-genetically encoded vulnerability to XPO1 inhibition in malignant rhabdoid tumors – expanding patient-driven discovery beyond the N-of-1Semantic proximity Read

Combining selinexor with alisertib to target the p53 pathway in neuroblastomaSemantic proximity Read

Emerging therapeutic targets for the treatment of malignant rhabdoid tumors.Semantic proximity Read

Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traitsSemantic proximity Read

Biology and Treatment of Rhabdoid TumorSemantic proximity Read